Related Experiment Video
Updated: Jul 18, 2026
07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Normal pituitary volumes in chronic schizophrenia
Kalliopi Tournikioti1, Michele Tansella, Cinzia Perlini
1Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy.
Psychiatry Research
|December 23, 2006
Summary
This study found normal pituitary gland size in chronic schizophrenia patients, unlike earlier findings. This suggests pituitary size may normalize as schizophrenia progresses, potentially due to reduced illness activity.
Area of Science:
- Neuroimaging
- Psychiatry
- Endocrinology
Background:
- Magnetic resonance imaging (MRI) studies indicate abnormal pituitary volumes in schizophrenia patients.
- Previous research reported enlarged pituitary volumes in early-stage psychosis and reduced volumes in established schizophrenia.
Purpose of the Study:
- To investigate pituitary gland volumes in a large cohort of patients with chronic schizophrenia.
- To compare pituitary volumes in chronic schizophrenia patients with healthy controls.
Main Methods:
- Utilized magnetic resonance imaging (MRI) to measure pituitary volumes.
- Compared 65 patients with chronic schizophrenia to 65 healthy individuals.
- Recruited participants from a defined geographical area (South Verona, Italy).
Main Results:
- No significant differences in pituitary volumes were found between chronic schizophrenia patients and healthy controls.
- This finding contrasts with some previous studies, possibly due to differences in sample age and gender.
Conclusions:
- Pituitary size may be normal in chronic schizophrenia, potentially normalizing with illness progression.
- Hypothesizes reduced hypothalamus-pituitary-adrenal axis activity contributes to normalization.
- Recommends longitudinal MRI studies and collection of hormonal data to further investigate these findings.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...